Lexington Biosciences, Inc. (CNSX:LNB) announced a non-brokered private placement of up to 10,000,000 units at a price of CAD 0.05 per unit for gross proceeds of up to CAD 500,000 on February 20, 2020. Each unit consists of one common share and one common share purchase warrant. Each warrant will be exercisable to buy one additional common share at a price of CAD 0.07 per share for a period of 24 months. The transaction is subject to all necessary regulatory approvals including the approval of the Canadian Securities Exchange. All securities issued in the transaction are subject to a statutory hold period of four months.